Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPembroke Vct Regulatory News (PEMB)

Share Price Information for Pembroke Vct (PEMB)

Share Price is delayed by 15 minutes
Get Live Data
92.00    0.00 (0.00%)
Bid:
90.00
Ask:
94.00
Spread: 4.00 (4.444%)
Market Cap: £269.20m
PEMB Live PriceLast checked at - London Stock Exchange

Intraday Pembroke Vct Share Chart

Directorate Change

28 Aug 2018 17:00

RNS Number : 0167Z
Pembroke VCT PLC
28 August 2018
Β 

Β 

Pembroke VCT plc (the "Company")

Β 

Director changes

Β 

The Board of the Company is pleased to announce the appointment of David Till as a non-executive director of the Company with effect from 28 August 2018.

Β 

David Till co-founded the Oakley Capital Group in 2002 with Peter Dubens. David plays a key role within the group and has overall responsibility for operations, finance, due diligence, compliance and fund formation. Oakley Capital Private Equity invests in and supports the continued growth and development of some of Europe's leading companies and seeks to build long-term relationships with talented entrepreneurial founders and managers. Over the past ten years Oakley has built expertise in three core sectors: TMT, Digital Consumer and Education, and has strong credentials and networks in these areas. Oakley Capital comprises three mid-market private equity funds comprising Fund I (€288 million), Fund II (€524 million) and Fund III which closed at €800 million in September 2017. The Funds generate strong returns for their limited partners as well as Oakley Capital Investments Limited, an AIM listed investment vehicle that invests in Oakley's private equity funds.

Β 

David holds a BA (Hons) in Economics from Essex University. He started his career in the British Army, then later qualified as a chartered accountant with Coopers & Lybrand, worked in industry as a finance director before returning to the profession holding senior M&A roles.

Β 

The Board also announces that Peter Dubens retires as a director of the Company on 28 August 2018.

Β 

Β 

For further details about the Company please either visit the Company's website:

Β 

Pembroke VCT plc

www.pembrokevct.com

Β 

or contact:

Β 

Pembroke VCT plc or Oakley Investment Managers LLP (Manager)

+44 20 7766 6900

Andrew Wolfson/Tamara Warren

Β 

Cornerstone Communications

+44 7917 080 365

Richard Acworth

Β 

The City Partnership (UK) Limited (Company Secretary)

+44 131 510 7465

Doreen Nic

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOALLFEITLITFIT
Date   Source Headline
7th Mar 202512:00 pmRNSUtilisation of Over-allotment Facility
28th Feb 20252:25 pmRNSIssue of Equity
17th Feb 20254:59 pmRNSDividend Declaration
10th Feb 20254:41 pmRNSIssue of Equity
6th Feb 20257:00 amRNSNet Asset Value(s)
2nd Jan 20254:00 pmRNSTotal Voting Rights
18th Dec 202411:26 amRNSIssue of Equity
9th Dec 20245:13 pmRNSHalf-year Report
4th Dec 202410:00 amRNSTotal Voting Rights
22nd Nov 20245:07 pmRNSIssue of Equity Replacement
20th Nov 20245:36 pmRNSIssue of Equity
4th Nov 202411:49 amRNSTotal Voting Rights
10th Oct 20243:36 pmRNSDirector/PDMR Shareholding
10th Oct 20243:35 pmRNSDirector/PDMR Shareholding
9th Oct 20243:24 pmRNSIssue of Equity
4th Oct 20245:54 pmRNSIssue of Equity
17th Sep 20246:25 pmRNSDirector/PDMR Shareholding
17th Sep 20246:21 pmRNSPurchase of Own Securities
13th Sep 20245:39 pmRNSDirectorate Change
12th Sep 20241:28 pmRNSResult of AGM
9th Sep 202412:03 pmRNSPublication of Prospectus
23rd Aug 202410:42 amRNSDividend Declaration
23rd Aug 202410:42 amRNSNet Asset Value(s)
20th Jun 20243:53 pmRNSIntention to Launch an Offer for Subscription
19th Jun 20245:01 pmRNSAnnual Financial Report
5th Jun 20247:00 amRNSTotal Voting Rights
30th May 20242:55 pmRNSDirectorate Change
8th May 20244:27 pmRNSIssue of Equity
3rd May 20241:56 pmRNSIssue of Equity
2nd May 20247:00 amRNSTotal Voting Rights
1st May 202412:05 pmRNSNotice of Close of Offer
23rd Apr 20244:50 pmRNSIssue of Equity - Dividend Reinvestment Scheme
12th Apr 20249:40 amRNSTransaction in Own Shares
8th Apr 20243:12 pmRNSIssue of Equity
2nd Apr 20244:04 pmRNSTotal Voting Rights
27th Mar 20243:56 pmRNSDirector/PDMR Shareholding
27th Mar 20243:52 pmRNSIssue of Equity
21st Mar 20249:46 amRNSIssue of Equity
1st Mar 20249:10 amRNSTotal Voting Rights
21st Feb 202411:58 amRNSDirector/PDMR Shareholding
21st Feb 202411:54 amRNSIssue of Equity
13th Feb 202412:15 pmRNSDirector/PDMR Shareholding
13th Feb 202412:09 pmRNSNet Asset Value(s)
13th Feb 202412:05 pmRNSDividend Declaration
5th Feb 202411:16 amRNSTotal Voting Rights
25th Jan 20243:30 pmRNSIssue of Equity
2nd Jan 20241:02 pmRNSTotal Voting Rights
7th Dec 20233:36 pmRNSIssue of Equity
1st Dec 202311:42 amRNSTotal Voting Rights
28th Nov 20231:48 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.